NCT03325621 - Phase 2a Study to Evaluate PRS-080 in Anemic Chronic Kidney Disease Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2017

Primary Completion Date

March 30, 2019

Study Completion Date

June 30, 2019

Conditions

Anemia of Chronic Kidney Disease

Interventions

BIOLOGICAL

PRS-080#022-DP

Biological/Vaccine: PRS-080#022-DP Hepcidin antagonism to mobilize iron and to treat anemia

BIOLOGICAL

PRS-080-Placebo#001

Placebo Comparator

Trial Locations (6)

MZV DaVita, Düsseldorf

Technical University Munich, Munich

University Hospital Brno, Brno

HDS - Klaudian's Hospital, Mladá Boleslav

Institute of Clinical and Experimental Medicine (ICEM), Prague

VFN Strahov, Prague